(Press-News.org) UNIVERSITY OF CALIFORNIA, BERKELEY'S HAAS SCHOOL OF BUSINESS -Too many vehicles on the highway inevitably slow down traffic. On the Internet information highway, consumers value high-speed Internet service, but there is little reason to think broadband traffic congestion will improve if the Federal Communications Commission abandons net neutrality, according to economic research.
In their paper, "The Economics of Network Neutrality," Ben Hermalin, Haas Economics Analysis and Policy Group, and Nicholas Economides, Berkeley-Haas visiting professor from NYU'S Stern School of Business, find that if Internet Service Providers known as ISPs initiate price discrimination in their pricing, a "recongestion effect" will occur. In other words, online delivery channels that are less congested at the onset of new pricing tiers will eventually become recongested when consumer behavior adjusts.
As the net neutrality debate continues, the study published in the RAND Journal of Economics (Vol. 43, No. 4, Winter 2012) provides a reminder of the potential fallout that multiple pricing might have on online traffic.
Hermalin and Economides use models to explore the economics of the current pricing regime known as "net neutrality," in which residential ISPs, such as ATT and Comcast, treat all content providers equally and don't directly charge them for the content they deliver to end users.
The models measure linear pricing versus price discrimination and compare the rate of congestion through the information pipeline between broadband providers and households under these different pricing strategies.
Hermalin says that many existing economic models examining price discrimination haven't taken the fixed capacity component seriously. Once the fixed capacity component is understood, "relaxing net neutrality becomes a bad thing," he says, "Except for the ISPs."
Linear pricing sets a fixed price for a product or service. Price discrimination is a pricing strategy that offers the same or similar product at different price points in order to maximize consumer demand or preference. For example, a type of breakfast cereal may come in two sizes: a small box for individuals and a large box for families. Even though the larger box of cereal may contain twice as much cereal, the price is not double the cost of the small box.
President Obama supports net neutrality but some ISPs continue to lobby the FCC to authorize "paid prioritization" or the creation of Internet "fast lanes" for those willing to pay more.
To better understand broadband congestion, consider Prof. Hermalin's hypothetical example of traffic on a real highway. If two of three lanes were reserved just for Mercedes Benz vehicles, drivers of Mercedes cars would enjoy a faster commute to and everyone else in the single remaining lane would be forced to slow down due to the added congestion. Predictably, Hermalin explains, more people would start buying Mercedes in order to take advantage of two lanes rather than one lane. The result? The two lanes that were previously less congested would recongest.
"Ultimately there is no real benefit because there is a fixed capacity on the highway," says Hermalin. "Likewise, the ISPs have a fixed amount of bandwidth to spread around unless they invest in more."
In the net neutrality debate, ISPs claim that in order to invest in more bandwidth, they need to charge content providers (Netflix, Amazon, etc.) either for streaming certain content or for facilitating content at premium speed. For years, the FCC has debated whether to alter the current system of a neutral network.
VIDEO:
Prof. Ben Hermalin's economic analysis of the net neutrality debate considers the impact of price discrimination and download limits. He discusses his work, co-authored by Prof. Nicholas Economides, Berkeley-Haas visiting...
Click here for more information.
The findings also suggest that while consumers may be willing to pay more for faster service, if net neutrality rules were relaxed, eventually the larger economic fallout would be that people will try to spend less in reaction to increasing prices.
The FCC's authority to regulate Internet traffic is currently under appeal as broadband providers challenge whether providing Internet service is a utility subject to FCC regulation.
INFORMATION:
Watch Ben Hermalin talk about his research:
https://www.youtube.com/watch?v=jN2gCSWUj_w&feature=youtu.be
See the Abstract: http://onlinelibrary.wiley.com/doi/10.1111/1756-2171.12001/full
See the authors' newest working paper, "The Strategic Use of Download Limits By A Monopoly Platform":
http://faculty.haas.berkeley.edu/hermalin/congested_platform_v21.pdf
Scientists at the University of Strathclyde and City University of New York have created methods that dramatically simplify the discovery of biological gels for food, cosmetics and biomedicine, as published in the journal Nature Chemistry.
Strathclyde's Dr Tell Tuttle and Professor Rein Ulijn, the director of nanoscience at City University New York's new advanced research centre who also holds a position at Strathclyde, believe their team's breakthrough dramatically simplifies discovery of functional gels that can be used in a wide range of applications.
Until now, ...
The drug daclatasvir (trade name Daklinza) has been available since August 2014 for the treatment of adults with chronic hepatitis C (CHC) infection. The German Institute for Quality and Efficiency in Health Care (IQWiG) examined in a dossier assessment whether this new drug offers an added benefit over the appropriate comparator therapy.
The drug manufacturer presented data for patients without cirrhosis of the liver who are infected with hepatitis C virus (HCV) genotype 1, and for patients with HCV genotype 4. However, these data are unsuitable in various aspects to ...
Pioneering new research by the University of Exeter could revolutionise global diagnostic procedures for one of the most common forms of epilepsy.
Scientists from Exeter have investigated using mathematical modelling to assess susceptibility to idiopathic generalised epilepsy (IGE) by analysing electrical activity of the brain while the patient is in a resting state.
Current diagnosis practices typically observe electrical activities associated with seizures in a clinical environment.
The ground-breaking research has revealed differences in the way that distant regions ...
"A tree must be bent while it is young," as one saying about learning a foreign language goes. In other words, the earlier you start learning a foreign language systematically, the better the language level will be in the long run. The second widely held view is that you need to be solid in your first language (L1) in order to develop good literacy skills in the foreign language. Linguist Simone Pfenninger from the University of Zurich has been examining these two myths in her five-year study involving Swiss high-school children in order to identify the optimal starting ...
Reston, Va. (December 9, 2014) - Cancer therapy can be much more effective using a new way to customize nuclear medicine treatment, researchers say in the December 2014 issue of The Journal of Nuclear Medicine. The process could also be useful for other diseases that could benefit from targeted radiation.
Targeted therapy with radiopharmaceuticals--radioactive compounds used in nuclear medicine for diagnosis or treatment--has great potential for the treatment of cancer, especially for cancer cells that have migrated from primary tumors to lymph nodes and secondary organs ...
London, United Kingdom, December 9, 2014 - As the Ebola Virus Diseases (EVD) epidemic continues to rage in West Africa, infectious diseases experts call attention to the striking lack of treatment guidelines. With over 16,000 total cases and more than 500 new infections reported per week, and probable underreporting of both cases and fatalities, the medical community still does not have specific approved treatment in place for Ebola, according to an editorial published in the International Journal of Infectious Diseases.
Not only are treatment guidelines lacking, but ...
Studying the social interaction of bears through the use of camera traps and visual observations requires that humans be able to tell individuals apart. A study done using volunteers to study the vulnerable Andean bear indicates that people can learn to identify individual bears, given a little practice. The research, done by San Diego Zoo conservationists with international collaborators using photos spanning many years, also indicates that young bears usually retain many of their unique markings as they grow older.
"Knowing, scientifically, that people who have been ...
Researchers from Johannes Gutenberg University Mainz (JGU) and the Julius Maximilian University of Würzburg are proposing potential new active substances for treating the dengue virus. Just like Ebola, dengue fever is also caused by a virus for which there is currently no cure and no vaccine and can be fatal.
In the quest for medication to treat the dengue virus, the scientific community is focusing on a particular enzyme of the pathogen, the protease known as NS2B/NS3. The reason for this is that inhibitors of similar proteases have been revealed to be very effective ...
JACKSONVILLE, Fla. -- A marker of immune function that predicts for better outcomes in patients treated with chemotherapy for triple negative breast cancer is also linked to improved prognosis in patients treated with chemotherapy for HER2-positive breast cancer. But that marker -- the quantity of tumor-infiltrating lymphocytes (S-TILs) in a biopsy -- appears irrelevant when trastuzumab is used.
And since trastuzumab, and not chemotherapy alone, is the standard of care for the HER2-positive sub-class of breast cancer, there is no need to test for these lymphocytes in ...
In patients with metastatic triple-negative breast cancer--a disease with no approved targeted therapies--infusion of pembrolizumab produced durable responses in almost one out of five patients enrolled in a phase-Ib clinical trial, according to data presented Dec. 10, at the 2014 San Antonio Breast Cancer Symposium.
The multi-center, non-randomized trial was designed to evaluate the safety, tolerability and antitumor activity of bi-weekly infusions of pembrolizumab (MK-3475, marketed as Keytruda®). The researchers enrolled 27 patients, aged 29 to 72 years, who had ...
